Why We Will Have A Revlimid transition vs. A Downward "Cliff" After 2025 | BMY Message Board Posts


Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  6390 of 10557  at  3/4/2021 11:54:07 AM  by

Biotech2050


 In response to msg 6389 by  tocentsworth
view thread

Why We Will Have A Revlimid transition vs. A Downward "Cliff" After 2025

I edited your title. CC-220 will canibalize revlimid and CC-92480 will canibalize pomalyst.
 
See my recent posts and take the time to listen to what KOLs like Dr Sagar Lonial and the patients’ group like Myeloma Crowd are saying. They eagerly await these cereblons which are x10 more efficacious than revlimid and less toxic. 
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 6  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
6392 Re: Why We Will Have A Revlimid transition vs. A Downward "Cliff" After 2025 JBWIN 11 3/4/2021 1:37:21 PM




Financial Market Data provided by
.
Loading...